• Title/Summary/Keyword: Hematologic

Search Result 580, Processing Time 0.024 seconds

Effects of Yuhyangjeongtong-san on Fracture Healing in Rats

  • Kim, Ki-Tae;Jo, Na-Young
    • The Journal of Korean Medicine
    • /
    • v.40 no.4
    • /
    • pp.61-71
    • /
    • 2019
  • Objectives: The purpose of this study is to determine the effect of Yuhyangjeongtong-san on the recovery of tibial fractures in rats. Methods: In this study, osteocalcin and Calcitonin, CTX-2, TGF-β and BMP-2, which are used as indicators of bone formation, were analyzed after hematologic fractures using experimental rats. In addition, the fracture union process was confirmed using X-rays. Results: Osteocalcin, Calcitonin and BMP-2 showed a significant increase compared with the control at 4 weeks. CTX-2 and TGF-β showed a significant increase compared with the control at 3 weeks. On X-ray, YJS treated group, as the experiment progressed, the boundary line became blurred, the bone outline was clearly visible, and the fracture recover was progressing. Conclusion: The findings suggest that YJS can play a significant role in the repair of fractures. Therefore YJS is likely to be used to treat fractures.

Eosinophil disorders (호산구이상증)

  • Kim, Sun Young
    • Clinical and Experimental Pediatrics
    • /
    • v.52 no.6
    • /
    • pp.643-648
    • /
    • 2009
  • Blood eosinophilia can be classified as either familial or acquired. Familial eosinophilia is a rare autosomal dominant disorder characterized by a stable eosinophil count. Acquired eosinophilia is classified further into a primary or secondary phenomenon depending on whether eosinophils are considered integral to the underlying disease. Primary eosinophilia is considered clonal in the presence of either a cytogenetic abnormality or bone marrow histological evidence of classified hematologic malignancies. Causes of secondary eosinophilia include infections, allergic or immunologic disorders, and drugs. Idiopathic eosinophilia belongs to a category of primary eosinophilia, and this is a diagnosis of exclusion. Cases with eosinophilia that lack evidence of clonality may be diagnosed as idiopathic hypereosinophilic syndrome after all causes of reactive eosinophilia have been eliminated. Genetic mutations involving the platelet-derived growth receptor genes (PDGFRA and PDGFRB) have been pathogenetically linked to clonal eosinophilia, and their presence predicts the treatment response to imatinib. In this review, I will present a clinical summary of both familial and acquired eosinophilia with emphasis on recent developments in molecular pathogenesis and treatment.

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients

  • Park, Jeong A
    • Clinical and Experimental Pediatrics
    • /
    • v.59 no.3
    • /
    • pp.105-113
    • /
    • 2016
  • Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary complication in patients with hematologic malignancies or autoimmune disorders. The current treatment options, which include corticosteroids, transfusions, extracorporeal membrane oxygenation (ECMO), and immunosuppressants, have been limited and largely unsuccessful. Recombinant activated factor VII (rFVIIa) has been successfully administered, either systemically or bronchoscopically, to adults for the treatment of DAH, but there are few data on its use in pediatric patients. The current literature in the PubMed database was reviewed to evaluate the efficacy and risk of rFVIIa treatment for DAH in pediatric patients. This review discusses the diagnosis and treatment of DAH, as well as a new treatment paradigm that includes rFVIIa. Additionally, the risks and benefits of off-label use of rFVIIa in pediatric patients are discussed.

Studies on Hematologic Values and Blood Chemistry Values of Normal Jindo Dogs - 2. Blood Chemistry for Jindo Dogs (진도견의 혈액상 및 혈액화학치에 관한 연구 - 제2보 진도견의 혈액화학치)

  • Rim Bong Ho;Park Nam Yong;Lee Bang Whan
    • Journal of the korean veterinary medical association
    • /
    • v.16 no.3
    • /
    • pp.143-149
    • /
    • 1980
  • Normal values for chemical components of blood serum were determined for Normal 37 females and 20 males of Jindo dogs, 1 to 6 years of age. The mean values, standard deviation and ranges of glucose, non-protein nitrogen, blood urea nitrogen, total protein

  • PDF

Acute Effects of Naphthalene on Hematologic Properties of flounder (Naphthalene에 노출된 넙치치어의 혈액학적 반응)

  • Lee, Kyoung-Seon;Ryu, Hyang-Mi
    • Proceedings of KOSOMES biannual meeting
    • /
    • 2009.06a
    • /
    • pp.167-169
    • /
    • 2009
  • 넙치 치어에 대한 Naphthalene의 급성독성을 조사하기 위하여 대조구($0{\mu}g/\ell$), 1000, 1800, 3200, 5200, $10000{\mu}g/\ell$의 6개의 Naphthalene 농도구를 실정하여 24시간 동안 노출험을 실시하고 혈액학적 성상을 분석하였다. 넙치치어에 대한 Naphthalene의 24h-$LC_{50}$$2346.19{\mu}g/\ell$를 나타냈다. 넙치의 혈액학적 반응에서 헤마토크리트값은 5600, $10000{\mu}g/\ell$의 농도에서 대조구와 비교하여 유의하게 증가하였고, 글루코스는 $10000{\mu}g/\ell$의 농도에서 유의하게 증가 하였다. 삼투압 농토는 3200, 5600, $10000{\mu}g/\ell$의 농노 구에서 유의하게 증가하였다. 반면, 이온 분석 결과 $Na^+$, $K^+$은 5600 및 $10000{\mu}g/\ell$ Naphthalene 농도구에서 유의하게 증가하였으나 $Cl^-$는 큰 차이를 보이지 않았다.

  • PDF

A Case of Eosinophilia with Bronchoalveolar Cell Carcinoma of Lung (기관지폐포성세포암에 동반된 호산구증다증 1례)

  • Kwon, Kyeong-Soon;Lee, Young-Hyun;Chung, Jae-Chun;Kim, Chong-Suhl;Kang, Myeun-Shik
    • Journal of Yeungnam Medical Science
    • /
    • v.4 no.1
    • /
    • pp.165-171
    • /
    • 1987
  • The solid and hematologic cancer are occasionally accompanied by peripheral blood eosinophilia and suggest tumor necrosis or wide dissemination, but the mechanisms underlying this curious relationship remain obscure. The association of this eosinophilic leukemoid reaction with carcinoma seems to occur must frequently with bronchogenic carcinoma. Several mechanisms for this association were considered: eosinophil chemotactic factor, eosinophilia mediated by T-lymphocyte, and eosinopoietic hormone. we are here reporting a case of bronchoalveolar cell carcinoma of lung associated with peripheral eosinophilia in a 60-year-old male patient.

  • PDF

A Case Report of Sjogren Syndrome (쉐그렌증후군의 임상 증례)

  • JK Choi;SC Yoon;HK Park
    • Journal of Oral Medicine and Pain
    • /
    • v.20 no.1
    • /
    • pp.29-37
    • /
    • 1995
  • We diagnosed a patient with chronic dry mouth for 3 years as definite Sjogren's syndrome by the criteria for diagnosis of Sjogren's syndorne proposed by the 1st international seminar on Sjogren's syndrome. The clinical immunologic , hematologic, scintigraphic, and histologic examinations were performed. The patient showed severe xeorstomia, keratoconjunctiva sicca, severe infiltration of lymphocytes in minor salivary glands, and evidences of autoantibodies. The patient's history and clinical findings excluded preexisting lymphoma, graft-versus-host disease, acquired immunodeficiency disease, and sarcoidosis.

  • PDF

Acute Variation of Hematological Parameters during 622 km Ultra-Marathon

  • Shin, Kyung-A;Kim, Young-Joo
    • Biomedical Science Letters
    • /
    • v.23 no.3
    • /
    • pp.208-214
    • /
    • 2017
  • To investigate the effects of strenuous physical exercise on commonly used hematological markers in subjects the intensive long running. Blood samples were obtained from nineteen participants in a 622 km ultra-marathon race before, 300 km and immediately after completion of the 622 km ultra-marathon. Samples were analyzed for total white cell count (WBC) and differential, total red cell count (RBC), hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), platelets, mean platelets volume (MPV), platelets distribution width (PDW). Significant increases were found in WBC, neutrophil and platelets at 622 km compared to the pre-race. RBC, hemoglobin and hematocrit decreased statistically significantly the race at 300 km and 622 km compared to pre-race. A wide range of hematological perturbations occur during 622 km ultra-marathon running but it was physiological changes within a reference range. The 622 km ultra-marathon is less likely to cause clinically significant hematologic changes in athletes.

Tumour Lysis Syndrome: Implications for Cancer Therapy

  • Mika, Denish;Ahmad, Sabrina;Guruvayoorappan, C.
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.8
    • /
    • pp.3555-3560
    • /
    • 2012
  • The tumour lysis syndrome (TLS) is a group of metabolic abnormalities caused by rapid and unexpected release of cellular components into the circulation as a result of massive destruction of rapidly proliferating malignant cells. It usually develops in patients with hematologic malignancies like acute lymphoid leukemia, non-Hodgkin and Burkitt's lymphoma after initiation of chemotherapy or may, rarely, occur spontaneously. Though TLS is seldom observed in relation to solid tumours, there have been reports of connections with examples such as lung, liver, breast, gastric carcinomas. The clinical manifestations of TLS include hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia. These indications if untreated lead to life-threatening complications such as acute renal failure, cardiac arrhythmias, seizures, and eventually death due to multiorgan failure. Therefore early detection of TLS is of vital importance. This can be accomplished by identification of high risk patients, implementation of suitable prophylactic measures andmonitoring of the electrolyte levels in patients undergoing chemotherapy.

Interferon Apha 2b for Treating Patients with JAK2V617F Positive Polycythemia Vera and Essential Thrombocytosis

  • Zhang, Zhi-Rong;Duan, Yan-Chao
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.4
    • /
    • pp.1681-1684
    • /
    • 2014
  • Objective: To investigate interferon (IFN) alpha 2 b for treating patients with JAK2V617F positive polycythemia vera (PV) and essential thrombocytosis (ET). Methods: Interferon alpha 2 b was used to treat patients with JAK2V617F positive PV and ET. In control group, hydroxyurea was used. Endpoint of study was to compare rates of hematological and molecular remission. Results: Patients in the interferon alpha 2 b group achieved higher rates of hematologic and molecular remission than patients in the hydroxyurea group, with a lower incidence of thrombosis. Conclusion: Compared with hydroxyurea, interferon alpha 2 b could reduce JAK2V617F load for patients with PV and ET, and achieve higher molecular remission, improve treatment efficacy and reduce complications.